...
首页> 外文期刊>Advances in Experimental Medicine and Biology >Efficacy of noninvasive mechanical ventilation in obese patients with chronic respiratory failure
【24h】

Efficacy of noninvasive mechanical ventilation in obese patients with chronic respiratory failure

机译:肥胖型慢性呼吸衰竭患者无创机械通气的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic respiratory failure (CRF) develops in a minority of obese patients. Noninvasive mechanical ventilation (NIMV) is a new optional treatment for such patients. The aim of this study was to evaluate the effectiveness of NIMV in obese patients with CRF. The material of the study consisted of 34 obese patients (body mass index 47.3 ± 7.9 kg/m2) with CRF (PaO 2 = 6.40 ± 0.93 kPa and PaCO2 = 8.67 ± 2.13 kPa) who were hypoxemic despite an optimal therapy. Thirteen patients had an overlap syndrome (OS)-chronic obstructive pulmonary disease (COPD) coexisting with obstructive sleep apnea syndrome (OSAS) and 21 patients had obesity-hypoventilation syndrome (OHS). Ventilation parameters were determined during polysomnography. The efficacy of NIMV was evaluated on the fifth day and after 1 year's home treatment. We observed a significant increase in the mean blood oxygen saturation during sleep in all patients; the increase was greater in patients with OHS (92.6 ± 1.4 %) than in patients with OS (90.4 ± 1.8 %). There was a significant improvement of diurnal PaO2 and PaCO2 on the fifth day of NIMV (mean PaO2 increase 2.1 kPa and PaCO2 decrease 0.9 kPa) and also after 1 year of home NIMV (mean PaO2 increase 1.9 kPa and PaCO2 decrease 2.4 kPa). Only one patient stopped treatment because of lack of tolerance during the observation period (1-3 years). In conclusion, NIMV is an effective and well tolerated treatment option in obese patients with CRF resulting in a rapid relief of respiratory disorders during sleep and a gradual, long-term improvement of gas exchange during the day, particularly in patients with OHS.
机译:少数肥胖患者会出现慢性呼吸衰竭(CRF)。无创机械通气(NIMV)是针对此类患者的新的可选治疗方法。这项研究的目的是评估NIMV在肥胖CRF患者中的有效性。该研究的材料包括34例肥胖患者(体重指数47.3±7.9 kg / m2),尽管采用了最佳疗法,但仍存在低氧血症,但CRF(PaO 2 = 6.40±0.93 kPa和PaCO2 = 8.67±2.13 kPa)。 13例患有重叠综合征(OS)的慢性阻塞性肺疾病(COPD)与阻塞性睡眠呼吸暂停综合征(OSAS)并存,还有21例患有肥胖低通气综合征(OHS)。在多导睡眠监测仪中确定通气参数。在家庭治疗的第五天和一年后评估NIMV的疗效。我们观察到所有患者在睡眠期间的平均血氧饱和度显着增加。 OHS患者(92.6±1.4%)的增加幅度大于OS患者(90.4±1.8%)的增加幅度。在NIMV的第五天,每日PaO2和PaCO2有显着改善(平均PaO2增加2.1 kPa,PaCO2减少0.9 kPa),以及在家庭NIMV一年后(平均PaO2增加1.9 kPa,PaCO2减少2.4 kPa)。在观察期内(1-3年),由于缺乏耐受性,只有一名患者停止治疗。总之,对于患有CRF的肥胖患者,NIMV是一种有效且耐受性良好的治疗选择,可在睡眠期间迅速缓解呼吸系统疾病,并在白天逐渐,长期改善气体交换,特别是在OHS患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号